SELECTED RECENT PUBLICATIONS
The Division of Alcoholism and Drug Abuse

         Listed below are selected publications by Divisional faculty which appeared, or are in press, in the last three years.  They are selected from those which have a substance abuse focus.

Aromin RA, Jr., Galanter M, Solhkhah R, Dermatis H, Bunt G. Preference for spirituality and twelve-step oriented approaches among adolescents in a residential therapeutic community. J Addict Dis. 2006; 25:89-96.

Banko JL, Merhav M, Sonenberg N, Rosenblum K, and Klann E. Behavioral alterations in mice that lack the translation repressor 4E-BP2. Neurobiol. Learn. Mem. 2007; 87:248-256.

Banko JL, Hou L, Poulin F, Sonenberg N, and Klann E. Regulation of eukaryotic initiation factor 4E by converging signaling pathways during metabotropic glutamate receptor-dependent long-term depression. J. Neurosci. 2006; 26:2167-2173.

Bartholow BN, Buchbinder S, Celum C, Goli V, Koblin B, Para M, Marmor M, Novak RM, Mayer K, Creticos C, Orozco-Cronin P, Popovic V, and Mastro TD for the VISION/VAX004 Study Team.  HIV sexual risk behavior over 36-months of follow-up in the world’s first HIV vaccine efficacy trial.  J Acq Immune Deficiency Syndr. 2005;39:90-101.

Brook DW, Brook JS, Rubenstone E, Zhang C, & Gerochi C. Cigarette smoking in the adolescent children of drug-abusing fathers. Pediatrics. 2006; 117(4):1339-1347.

Brook DW, Saar NS, Brook JS. Earlier violent television exposure and later drug dependence. Am J Addict. 2008; 17(4):271-277.

Brook JS, Balka EB, Ning Y, Whiteman M, Finch SJ. Smoking involvement during adolescence among African Americans and Puerto Ricans: Risks to psychological and physical well-being in young adulthood. Psychol Reports. 2006; 99:421-438.

Brook JS, Ning Y, Brook DW. Personality risk factors associated with trajectories of tobacco use. Am J Addict. 2006; 15(6):426-433.

Brown LS, Kritz S, Goldsmith RJ, Bini EJ, Robinson J, Alderson D, Rotrosen J. Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs. Pub Health Reports. 2007; 122:441.

Bruce RD, Altice FL, Gourevitch MN, Friedland GH.  A review of pharmacokinetic drug interactions between opioid agonist therapy and antiretroviral medications:  implications for clinical practice.  J Acq Immune Deficiency Syndr. 2006; 41:563-572.

Cabeza de Vaca S, Kannan P, Pan Y, Jiang N, Sun Y, Carr KD. The adenosine A2a receptor agonist, CGS-21680, blocks excessive rearing, acquisition of wheel running, and increases nucleus accumbens CREB phosphorylation in chronically food-restricted rats. Brain Res. 2007; 1142:100-109.

Carr, KD.  Food restriction: enhancing effects on drug reward and striatal cell signaling. Physiol Behav. 2007; 91:459-472.

Carr KD, Cabeza de Vaca S, Sun Y, Chau LS, Pan Y. Effects of the MEK inhibitor, SL-327, on rewarding, motor- and cellular-activating effects of d-amphetamine and SKF-82958, and their augmentation by food restriction.  Psychopharmacol. September 3, 2008. Epub ahead of print.

Castro FG, Brook JS, Brook DW, Rubenstone E. Paternal, perceived maternal, and youth risk factors as predictors of youth stage of substance use. J Addict Dis. 2006; 25(2):65-76.

Chan GM, Stajic M, Marker EK, Hoffman RS, Nelson LS. Testing positive for methadone and either a tricyclic antidepressant or a benzodiazepine is associated with an accidental overdose death: Analysis of medical examiner data. Acad Emerg Med. 2006;13:543-7.

Chan GM, Sharma R, Price D, Hoffman RS, Nelson LS. Phentolamine therapy for cocaine-associated acute coronary syndrome. J Med Toxicol. 2006;2:108-111.

Cortes RY, Arevalo JC, Magby JP, Chao MV, and Plummer MR. Developmental and activity-dependent regulation of ARMS/Kidins220 in cultured rat hippocampal neurons.  Dev Neurobiol. 2007; 67(13):1687-1698.

De Leon, G. Theraputic communities.  In: Galanter M & Kleber HD (Eds.)  The American Psychiatric Publishing Textbook of Substance Aabuse (3rd Edition, pp. 485-501). Washington, DC: American Psychiatric Publishing, Inc. 2005.

De Leon G, Jones HE, Stitzer M. Medication free treatment of opioid  dependence. In E.C. Strain & M.L. Stitzer (Eds.), The Treatment of Opioid Dependence (pp. 323-345). Baltimore MD: Johns Hopkins University Press; 2005.

Dermatis H, Galanter M. Clinical advances in pharmacological and integrated  treatment approaches for alcohol and drug use disorders. Focus. 2007; 5:141-150.

Dermatis H, Galanter M, Trujillo M, Rahman-Dujarric C, LaGressa D. Evaluation of a model for the treatment of combined mental illness and substance abuse: The Bellevue model for peer led treatment in systems change. J Addic Dis. 2006; 25:69-77.

Domeniconi M, Hempstead BL, Chao MV. Pro-NGF secreted by astrocytes promotes motor neuron cell death.  Mol Cell Neurosci. 2007; 34:271-279.  

Fallon S, Shearman E, Sershen H, and Lajtha A. The effects of glutamate and GABA receptor antagonists on nicotine-induced neurotransmitter changes in cognitive areas.  Neurochem Res. 2007; 32:535-553.

Fiellin DA, Friedland GH, Gourevitch MN.  Opioid Dependence:  rationale for and efficacy of existing and new treatments.  Clinical Infectious Diseases. 2006; 43 Suppl 4:S173-S177.

Galanter M. Spirituality and recovery in Twelve-Step programs: An empirical model. J Substance Abuse. 2007; 33:265-272.

Galanter M. Spirituality, evidenced-based medicine, and Alcoholics Anonymous. Am J Psychiatry. 2008; 165:1514-1516.

Galanter M, Glickman L, Dermatis H, Tracy K, McMahon C. Addressing patients’ spirituality in medical treatment. Primary Psychiatry. 2008; 15(9):82-90.

Galanter M, Kaskutas LA. (eds.) Recent developments in Alcoholism Vol. XVIII. Research on Alcoholics Anonymous and Spirituality in Addiction Recovery. New York, NY: Kluwer/Plenum Press. 2008.

Galanter M, Kleber HK (eds). Textbook of Substance Abuse Treatment (4th Edition). Washington, DC: American Psychiatric Publishing. 2008.

Gordon AJ, Fiellin DA, Friedmann PD, Gourevitch MN, Kraemer KL, Arnsten JH, Saitz D.  2009 update in addiction medicine for the primary care clinician.  J Gen Int Med.  2008; 23(12):2112-2116. 

Gourevitch MN, Chatterji P, Deb N, Schoenbaum EE, Turner BJ.  On-site medical care in methadone maintenance: associations with health care use and expenditures.  J Subst Abuse Treat.  2007; 32:143-151.

Greger IH, Akamine P, Khatri L, Ziff EB. Developmentally regulated, combinatorial RNA processing modulates AMPA receptor biogenesis. Neuron. 2006; 51:85-97.

Hack JB, Hoffman RS, Nelson LS. Resistant Alcohol Withdrawal: Does an unexpectedly large sedative requirement identify these patients early? J Med Toxicol 2006; 2: 55-9.

Hao J, Cabeza de Vaca S, Pan Y, Carr KD.  Effects of central leptin infusion on the reward-potentiating  effects of d-amphetamine. Brain Res. 2006; 1087:123-133.

Harris KA, Arnsten JH, Joseph H, Hecht J, Marion IJ, Juliana P, Gourevitch MN.  A five year evaluation of a methadone medical maintenance program.  J Subst Abuse Treat. 2006; 31:433-8. 

Hopper H, Shinn B, Laska E, Meisner M, Wanderling J. Estimating numbers of unsheltered homeless people through plant-capture and post-count survey methods. Am J Pub Health. 2008; 98(8):1438-1442.

Hu D, Cao P, Thiels E, Chu CT, Wu GY, Oury T, Klann E.  Hippocampal long-term potentiation, memory, and longevity in mice that overexpress mitochondrial superoxide dismutase. Neurobiol Learn Mem. 2007; 87:372-384.

Johnson J G, Cohen P, Kasen S, Brook J S. Parental concordance and offspring risk for anxiety, conduct, depressive, and substance use disorders. Psychopathol. 2008; 2(2):124-128.

Jordan BA, Ziff EB. Getting to synaptic complexes through systems biology. Genome Biol. 2006;7:214.

Klann E, Sweatt JD. Altered protein synthesis is a trigger for long-term memory formation. Neurobiol Learn Mem. 2008; 89:247-259.

Knowlton AR, Arnsten JH, Gourevitch MN, Eldred L, Wilkinson J, Dawson-Rose C, Buchanan A, Purcell DW & the INSPIRE Team.  Microsocial environmental influences on HAART outcomes among active injection drug users: The role of informal caregiving and household factors.  J Acq Immune Deficiency Syndr. 2007; 46 Suppl 2:S110-119.

Kritz S, Brown LS, Goldsmith J, Bini EJ, Robinson J, Alderson D, Novo P, Rotrosen J.  States and substance abuse treatment programs: funding and guidelines for infection-related services. Am J Pub Health. 2008; 98:824

Latka MH, Metsch L, Mizuno Y, Tobin K, Mackenzie S, Arnsten JH, Gourevitch MN.  Unprotected sex among HIV-positive injection drug using women and their serodiscordant male partners:  role of personal and partnership influences.  J Acq Immune Deficiency Syndr.  2006; 42:222-228.

Lee JD, Triola M, Gillespie C, Gourevitch MN, Hanley K, Truncali A, Zabar S, Kalet A. Working with patients with alcohol problems: a controlled trial of the impact of a rich media web module on medical student performance.  J Gen Int Med. 2008; 23:1006-9.

Litwin AH, Kunins HV, Berg KM, Federman AD, Heavner KK, Gourevitch MN, Arnsten JH.  A nationwide survey of addiction medicine physicians and care for hepatitis C.  J Subst Abuse Treat.  2007; 33:99-105.

McNeely J, Arnsten JH, Gourevitch MN.  Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey.  Harm Reduction J. 2006; 3:1-8.

McNeely J, Arnsten JH, Langrod JL, Gourevitch MN.  Improving access to sterile syringes and safe syringe disposal for injection drug users in methadone maintenance treatment.  Journal of Substance Abuse Treatment. 2006;31:51-57. 

Ma L, Marmor M, Zhong P, Zekeng L, Su B, Nyambi P.  Distribution of CCR2-64I and SDF1- 3´A alleles and HIV status in 7 ethnic populations of Cameroon. J Acq Immune Deficiency Syndr. 2005; 40:89-95.

Marcus SE, Pahl K, Ning Y, Brook JS. Pathways to smoking cessation among African American and Puerto Rican young adults. Am J Pub Health.  2007; 97(8);1444-1448.

Marmor M, Hertzmark K, Thomas SM, Halkitis PN, Vogler M. Resistance to HIV infection. J Urban Hlth. 2006; 83:5-17.

Metrikin AS, Zwarenstein M, Steinberg MH, Van der Vyver E, Maartens G, Wood R: Is HIV /AIDS a primary care disease? Appropriate levels of outpatient care for patients with HIV/AIDS. AIDS. 1995; 9:619-623. 

Mizuno Y, Wilkinson JD, Santibanez S, Dawson Rose C, Knowlton A, Handley K, Gourevitch MN, and the INSPIRE Team.  Correlates of health care utilization among HIV-seropositive injection drug users.  AIDS Care. 2006; 18:417-25.

Nixon RA.  Autophagy in neurodegenerative disease:  friend, foe, or turncoat? Trends in Neurosci. 2006; 29:528-535 PMID:16859759.

Nowak KL, Vinod KY, Hungund BL. Pharmacological manipulation of CB1 receptor function alters development of tolerance to alcohol. Alcohol Alcoholism. 2006; 41: 24-32.

Paizis M, Ross S, Dermatis H. Issues in treating patients with combined substance abuse and Axes I and II general psychiatric disorders. Subst Abuse. 2006; 26(1):43-4.

Pan Y, Siregar E, Carr KD. Striatal cell signaling in chronically food-restricted rats under basal conditions and in response to brief handling,  Neurosci Letters. 2006; 393:243-248.

Reid MS, Fallon B, Sonne S, Brown N, Lawrence SJr, Kritz SA, Goldsmith RJ, Bini EJ, Rotrosen J, Baker S, Robinson J, McAuliffe P. Characteristics of substance abuse treatment programs providing services for HIV/AIDS, hepatitis C virus infection, and sexually transmitted infections: the National Drug Abuse Treatment Clinical Trials Network. J Subst Abuse Treat. 2006; 30:315.

Reid MS, Fallon B, Sonne S, Flammino F, Nunes EV, Jiang H, Kourniotis E, Lima J, Brady R, Burgess C, Arfken C, Pihlgren E, Giordano L, Starosta A, Robinson J, Rotrosen J. Smoking cessation treatment in community-based substance abuse rehabilitation programs. J Subst Abuse Treat. 2008; 35:68.

Ross S. Alcohol use disorders in the elderly. Primary Psychiatry. 2005;12(1):32-40.

Ross S. The group therapy of substance abuse. J Eastern Grp Psychother Soc. 2006; 30(1):65-69.

Ross S, Cidambi I, Dermatis H, Weinstein J, Ziedonis D, Roth S, Galanter M. Music therapy: a novel motivational approach for dually diagnosed patients. J Addict Dis. 2008; 27(1):41-53.

Rossi S, Singer S, Shearman E, Sershen H, Lajtha A. The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes.  Neurochem Res. 2005; 30:541-558.

Rotrosen J, Debowy D, Minerly C, Di Martino A, Castellanos FX. Reliability of low frequency reaction time oscillations in adult controls and preliminary data in patients with psychiatric and addictive disorders [Abstract]. Neuropsychopharmacol. 2006; 31:S192.

Sachs BD, Baillie GS, McCall JR, Passino MA, Schachtrup C, Wallace DA, Dunlop AJ, MacKenzie KF, Klussmann E, Lynch MJ, Sikorski SL, Nuriel T, Tsigelny I, Zhang J, Houslay MD, Chao MV, Akassoglou K.  Neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway.  J Cell Biol. 2007; 177:1119-1132.  

Shah SS, McGowan JP, Klein RS, Converse PJ, Blum S, Gourevitch MN.  Agreement between mantoux skin testing and QuantiFERON®-TB assay using dual mycobacterial antigens in current and former injection drug users.  Medical Science Monitor. 2006; 12:MT11-16.

Shearman E, Rossi S, Sershen H, Hashim A, Lajtha A. Locally administered low  nicotine induced neurotransmitter changes in areas of cognitive function. Neurochem Res. 2005; 30:1055-1066.

Shearman E, Fallon S, Sershen H, Lajtha A. Nicotine-induced monoamine neurotransmitter changes in the brain of adolescent rats. Brain Res Bull. 2008; 76:626-639.

Shrikhande A, Dermatis H, Galanter M. The need for understanding the role of spirituality in Twelve-Step programs. Subst Abuse. 2008; 29(4):1-3.

Solhkhah R, Galanter M, Dermatis H, Daly J, Bunt G. Spiritual orientation among adolescents in a drug-free residential therapeutic community. J Child Adolescent Subst Abuse. 2009; 18:57-71.

Tuchman E. Exploring the prevalence of menopause symptoms in midlife women in methadone maintenance treatment.  Soc Work Health Care. 2007; 45(4):43-62.

Tuchman E, Drucker E.  Lessons learned in OBOT: three case studies of women who did not succeed in pharmacy-based methadone treatment.  Addictive Disorders & Their Treatment. 2008;7(3):129-141.

Tuchman E, Gregory C, Simson J, Drucker E.  Safety, efficacy, and feasibility of office based prescribing and community pharmacy dispensing of methadone:  results of a pilot study in New Mexico. Addictive Disorders & Their Treatment. 2006;5(2):43-51.

Vinod KY, Hungund BL. Role of the endocannabinoid system in depression and suicide. Trends in Pharmacol Sci. 2006; 27:539-45.

Westreich LM. Helping the Addict You Love, The New Effective Program for Getting the Addict Into Treatment.  New York: Simon & Schuster; 2007.

Whitley SD, Kunins HV, Arnsten JH, Gourevitch MN.  Co-locating buprenorphine with methadone maintenance and outpatient chemical dependency services.  J Subst Abuse Treat.  2007; 33:85-90.

Wiese S, Jablonka S, Holtmann B, Orel N, Rajagopal R, Chao MV, Sendtner M. Adenosine receptor A2A-R contributes to motoneuron survival by transactivating the tyrosine kinase receptor TrkB. Proc. Natl Acad Sci. 2007; 104, Epub Oct 16.  

Zhu J, Reith MEA. Role of dopamine transporter in the action of psychostimulants, nicotine, and other drugs of abuse. CNS  Neurol Disord Drug Targets. 2008; 7(5):393-4